Apollon Wealth Management’s Vir Biotechnology VIR Stock Holding History

Apollon Wealth Management’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$121K	–	1466
2025 Q4	$121K	Hold	20,000	–	–	﹤0.01%	1260
2025 Q3	$114K	Buy	20,000 +10,000	+100%	+$51.1K	﹤0.01%	1265
2025 Q2	$50.4K	Buy	+10,000	New	+$53.6K	﹤0.01%	1240

Other funds holding VIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Apollon Wealth Management's VIR Position: Q1 2026 in Review

Apollon Wealth Management sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 20,000 shares — an estimated $121K sold.

Apollon Wealth Management first reported a position in VIR in Q2 2025 and held it in 3 quarters. The position peaked at $121K in Q4 2025. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

Apollon Wealth Management reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
Apollon Wealth Management sold 20,000 Vir Biotechnology shares in Q1 2026, an estimated $121K.
Apollon Wealth Management first reported a position in Vir Biotechnology in Q2 2025 and held it in 3 quarters.
Apollon Wealth Management's Vir Biotechnology position peaked at $121K in Q4 2025.
251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.